Ghent University Academic Bibliography

Advanced

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

Filip Baert, Elien Glorieus, Cathérine Reenaers, Geert D'Haens, Harald Peeters UGent, Dennis Franchimont, Olivier Dewit, Philippe Caenepeel, Edouard Louis and Gert Van Assche (2013) JOURNAL OF CROHNS & COLITIS. 7(2). p.154-160
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
Adalimumab, Dose escalation, Dose de-escalation, Crohn's disease, DISEASE, INFLIXIMAB, THERAPY, EXPERIENCE, TRIAL
journal title
JOURNAL OF CROHNS & COLITIS
J. Crohns Colitis
volume
7
issue
2
pages
154 - 160
Web of Science type
Article
Web of Science id
000314901400009
JCR category
GASTROENTEROLOGY & HEPATOLOGY
JCR impact factor
3.562 (2013)
JCR rank
20/75 (2013)
JCR quartile
2 (2013)
ISSN
1873-9946
DOI
10.1016/j.crohns.2012.03.018
language
English
UGent publication?
no
classification
A1
id
8552389
handle
http://hdl.handle.net/1854/LU-8552389
date created
2018-02-28 17:05:36
date last changed
2018-05-17 09:56:23
@article{8552389,
  author       = {Baert, Filip and Glorieus, Elien and Reenaers, Cath{\'e}rine and D'Haens, Geert and Peeters, Harald and Franchimont, Dennis and Dewit, Olivier and Caenepeel, Philippe and Louis, Edouard and Van Assche, Gert},
  issn         = {1873-9946},
  journal      = {JOURNAL OF CROHNS \& COLITIS},
  keyword      = {Adalimumab,Dose escalation,Dose de-escalation,Crohn's disease,DISEASE,INFLIXIMAB,THERAPY,EXPERIENCE,TRIAL},
  language     = {eng},
  number       = {2},
  pages        = {154--160},
  title        = {Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients},
  url          = {http://dx.doi.org/10.1016/j.crohns.2012.03.018},
  volume       = {7},
  year         = {2013},
}

Chicago
Baert, Filip, Elien Glorieus, Cathérine Reenaers, Geert D’Haens, Harald Peeters, Dennis Franchimont, Olivier Dewit, Philippe Caenepeel, Edouard Louis, and Gert Van Assche. 2013. “Adalimumab Dose Escalation and Dose De-escalation Success Rate and Predictors in a Large National Cohort of Crohn’s Patients.” Journal of Crohns & Colitis 7 (2): 154–160.
APA
Baert, Filip, Glorieus, E., Reenaers, C., D’Haens, G., Peeters, H., Franchimont, D., Dewit, O., et al. (2013). Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients. JOURNAL OF CROHNS & COLITIS, 7(2), 154–160.
Vancouver
1.
Baert F, Glorieus E, Reenaers C, D’Haens G, Peeters H, Franchimont D, et al. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients. JOURNAL OF CROHNS & COLITIS. 2013;7(2):154–60.
MLA
Baert, Filip, Elien Glorieus, Cathérine Reenaers, et al. “Adalimumab Dose Escalation and Dose De-escalation Success Rate and Predictors in a Large National Cohort of Crohn’s Patients.” JOURNAL OF CROHNS & COLITIS 7.2 (2013): 154–160. Print.